Stay updated with breaking news from Ronald Silver. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
StockNews.com upgraded shares of Ironwood Pharmaceuticals (NASDAQ:IRWD – Get Rating) from a hold rating to a buy rating in a report published on Friday morning. Separately, TheStreet raised shares of Ironwood Pharmaceuticals from a c rating to a b- rating in a research report on Wednesday, January 19th. Two research analysts have rated the stock […]
Foundry Partners LLC cut its stake in Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD – Get Rating) by 7.3% during the 4th quarter, Holdings Channel.com reports. The firm owned 827,733 shares of the biotechnology company’s stock after selling 65,337 shares during the period. Foundry Partners LLC’s holdings in Ironwood Pharmaceuticals were worth $9,651,000 as of its most recent […]